Barriers to and facilitators of first-line treatment intensification (TI) in metastatic castration-sensitive prostate cancer (mCSPC) by practice setting and intensification frequency: A sub-analysis of IMPLEMENT.
| Published in: | Journal of Clinical Oncology Vol. 43; pp. 48 - 336 |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Journal Article |
| Published: |
American Society of Clinical Oncology
2/20/2025 Supplement 5
|
| Online Access: | View this record in EBSCOhost |
| Description not available. |